Literature DB >> 1955774

Role of mucosal T-cell-generated cytokines in epithelial cell injury.

S R Targan1, R L Deem, F Shanahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1955774     DOI： 10.1007/bf02919744

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  47 in total

1.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

Authors:  P S Linsley; E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.

Authors:  R C Budd; J C Cerottini; C Horvath; C Bron; T Pedrazzini; R C Howe; H R MacDonald
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

3.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

4.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.

Authors:  A Weiss; B Manger; J Imboden
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

Review 6.  Immunologic mechanisms in intestinal diseases.

Authors:  S R Targan; M F Kagnoff; M D Brogan; F Shanahan
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

7.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.

Authors:  L M Green; J L Reade; C F Ware; P E Devlin; C M Liang; J J Devlin
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

10.  Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.

Authors:  G E Ranges; A Zlotnik; T Espevik; C A Dinarello; A Cerami; M A Palladino
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307
View more
  3 in total

1.  Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.

Authors:  M W Leach; A G Bean; S Mauze; R L Coffman; F Powrie
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 2.  Intestinal epithelial function: the case for immunophysiological regulation. Implications for disease (2).

Authors:  D M McKay; M H Perdue
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 3.  Immunomodulator therapy in inflammatory bowel disease.

Authors:  P M Choi; S R Targan
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.